124 related articles for article (PubMed ID: 27385126)
41. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
42. DNA methylation in oral squamous cell carcinoma: molecular mechanisms and clinical implications.
González-Ramírez I; García-Cuellar C; Sánchez-Pérez Y; Granados-García M
Oral Dis; 2011 Nov; 17(8):771-8. PubMed ID: 21781230
[TBL] [Abstract][Full Text] [Related]
43. CRHR1 promoter hypomethylation: An epigenetic readout of panic disorder?
Schartner C; Ziegler C; Schiele MA; Kollert L; Weber H; Zwanzger P; Arolt V; Pauli P; Deckert J; Reif A; Domschke K
Eur Neuropsychopharmacol; 2017 Apr; 27(4):360-371. PubMed ID: 28233670
[TBL] [Abstract][Full Text] [Related]
44. Epigenetic imprinting during assisted reproductive technologies: The effect of temporal and cumulative fluctuations in methionine cycling on the DNA methylation state.
Hoeijmakers L; Kempe H; Verschure PJ
Mol Reprod Dev; 2016 Feb; 83(2):94-107. PubMed ID: 26660493
[TBL] [Abstract][Full Text] [Related]
45. Aberrantly methylated DNA as a biomarker in breast cancer.
Kristiansen S; Jørgensen LM; Guldberg P; Sölétormos G
Int J Biol Markers; 2013; 28(2):141-50. PubMed ID: 23564623
[TBL] [Abstract][Full Text] [Related]
46. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
47. The inactive X chromosome is epigenetically unstable and transcriptionally labile in breast cancer.
Chaligné R; Popova T; Mendoza-Parra MA; Saleem MA; Gentien D; Ban K; Piolot T; Leroy O; Mariani O; Gronemeyer H; Vincent-Salomon A; Stern MH; Heard E
Genome Res; 2015 Apr; 25(4):488-503. PubMed ID: 25653311
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic pathogenesis of human papillomavirus in upper aerodigestive tract cancers.
Talukdar FR; Ghosh SK; Laskar RS; Kannan R; Choudhury B; Bhowmik A
Mol Carcinog; 2015 Nov; 54(11):1387-96. PubMed ID: 25213493
[TBL] [Abstract][Full Text] [Related]
49. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics.
Laskar RS; Ghosh SK; Talukdar FR
Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895
[TBL] [Abstract][Full Text] [Related]
50. A multi-method approach to the molecular diagnosis of overt and borderline 11p15.5 defects underlying Silver-Russell and Beckwith-Wiedemann syndromes.
Russo S; Calzari L; Mussa A; Mainini E; Cassina M; Di Candia S; Clementi M; Guzzetti S; Tabano S; Miozzo M; Sirchia S; Finelli P; Prontera P; Maitz S; Sorge G; Calcagno A; Maghnie M; Divizia MT; Melis D; Manfredini E; Ferrero GB; Pecile V; Larizza L
Clin Epigenetics; 2016; 8():23. PubMed ID: 26933465
[TBL] [Abstract][Full Text] [Related]
51. MicroRNAs and Epigenetics.
Moutinho C; Esteller M
Adv Cancer Res; 2017; 135():189-220. PubMed ID: 28882223
[TBL] [Abstract][Full Text] [Related]
52. Cancer epigenetics.
Weber W
Prog Mol Biol Transl Sci; 2010; 95():299-349. PubMed ID: 21075335
[TBL] [Abstract][Full Text] [Related]
53. SNP rs16906252C>T Is an Expression and Methylation Quantitative Trait Locus Associated with an Increased Risk of Developing MGMT-Methylated Colorectal Cancer.
Kuroiwa-Trzmielina J; Wang F; Rapkins RW; Ward RL; Buchanan DD; Win AK; Clendenning M; Rosty C; Southey MC; Winship IM; Hopper JL; Jenkins MA; Olivier J; Hawkins NJ; Hitchins MP
Clin Cancer Res; 2016 Dec; 22(24):6266-6277. PubMed ID: 27267851
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic profiling joins personalized cancer medicine.
Heyn H; Méndez-González J; Esteller M
Expert Rev Mol Diagn; 2013 Jun; 13(5):473-9. PubMed ID: 23782254
[TBL] [Abstract][Full Text] [Related]
55. Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.
Puneet ; Kazmi HR; Kumari S; Tiwari S; Khanna A; Narayan G
Pathol Oncol Res; 2018 Oct; 24(4):757-770. PubMed ID: 29552712
[TBL] [Abstract][Full Text] [Related]
56. Potential biomarkers in gallbladder cancer: present status and future directions.
Srivastava K; Srivastava A; Mittal B
Biomarkers; 2013 Feb; 18(1):1-9. PubMed ID: 22931385
[TBL] [Abstract][Full Text] [Related]
57. Morphology-oriented epigenetic research.
Kitazawa S; Haraguchi R; Kitazawa R
Histochem Cell Biol; 2018 Jul; 150(1):3-12. PubMed ID: 29721644
[TBL] [Abstract][Full Text] [Related]
58. Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy.
Miller-Delaney SF; Bryan K; Das S; McKiernan RC; Bray IM; Reynolds JP; Gwinn R; Stallings RL; Henshall DC
Brain; 2015 Mar; 138(Pt 3):616-31. PubMed ID: 25552301
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression.
Cai Q; Jin L; Wang S; Zhou D; Wang J; Tang Z; Quan Z
Oncotarget; 2017 Jul; 8(29):47957-47968. PubMed ID: 28624787
[TBL] [Abstract][Full Text] [Related]
60. [Epigenetics and development: genomic imprinting].
Gabory A; Dandolo L
Med Sci (Paris); 2005 Apr; 21(4):390-5. PubMed ID: 15811304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
